Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the BD MAX open system

SARS-CoV-2 has spread rapidly, causing deaths worldwide. In this study, we evaluated the performance of the BD MAX Open System module for identifying viral pathogens, including SARS-CoV-2, in nasopharyngeal specimens from individuals with symptoms of upper respiratory tract infection. We developed a...

Full description

Saved in:
Bibliographic Details
Main Authors: Hsing-Yi Chung, Ming-Jr Jian, Chih-Kai Chang, Jung-Chung Lin, Kuo-Ming Yeh, Chien-Wen Chen, Sheng-Kang Chiu, Yi-Hui Wang, Shu-Jung Liao, Shih-Yi Li, Shan-Shan Hsieh, Shih-Hung Tsai, Cherng-Lih Perng, Ji-Rong Yang, Ming-Tsan Liu, Feng-Yee Chang, Hung-Sheng Shang
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Emerging Microbes and Infections
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2021.1873073
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850030557203791872
author Hsing-Yi Chung
Ming-Jr Jian
Chih-Kai Chang
Jung-Chung Lin
Kuo-Ming Yeh
Chien-Wen Chen
Sheng-Kang Chiu
Yi-Hui Wang
Shu-Jung Liao
Shih-Yi Li
Shan-Shan Hsieh
Shih-Hung Tsai
Cherng-Lih Perng
Ji-Rong Yang
Ming-Tsan Liu
Feng-Yee Chang
Hung-Sheng Shang
author_facet Hsing-Yi Chung
Ming-Jr Jian
Chih-Kai Chang
Jung-Chung Lin
Kuo-Ming Yeh
Chien-Wen Chen
Sheng-Kang Chiu
Yi-Hui Wang
Shu-Jung Liao
Shih-Yi Li
Shan-Shan Hsieh
Shih-Hung Tsai
Cherng-Lih Perng
Ji-Rong Yang
Ming-Tsan Liu
Feng-Yee Chang
Hung-Sheng Shang
author_sort Hsing-Yi Chung
collection DOAJ
description SARS-CoV-2 has spread rapidly, causing deaths worldwide. In this study, we evaluated the performance of the BD MAX Open System module for identifying viral pathogens, including SARS-CoV-2, in nasopharyngeal specimens from individuals with symptoms of upper respiratory tract infection. We developed and validated a rapid total nucleic acid extraction method based on real-time reverse transcription-polymerase chain reaction (RT-PCR) for the reliable, high-throughput simultaneous detection of common cold viral pathogens using the BD MAX Platform. The system was evaluated using 205 nasopharyngeal swab clinical samples. For assessment of the limit of detection (LoD), we used SARS-CoV-2, influenza A/B, and respiratory syncytial virus (RSV) RNA standards. The BD MAX dual multiplex real-time RT-PCR panel demonstrated a sensitivity comparable to that of the World Health Organization-recommended SARS-CoV-2 assay with an LoD of 50 copies/PCR. The LoD of influenza A/B and RSV was 100–200 copies/PCR. The overall percent agreement between the BD MAX panel and laboratory-developed RT-PCR test on 55 SARS-CoV-2-positive clinical samples was 100%. Among the 55 positive cases of COVID-19 analysed, no coinfection was detected. The BD MAX rapid multiplex PCR provides a highly sensitive, robust, and accurate assay for the rapid detection of SARS-CoV-2, influenza A/B, and RSV.
format Article
id doaj-art-ff95c37150bd479b96a94ea5d9a08a7d
institution DOAJ
issn 2222-1751
language English
publishDate 2021-01-01
publisher Taylor & Francis Group
record_format Article
series Emerging Microbes and Infections
spelling doaj-art-ff95c37150bd479b96a94ea5d9a08a7d2025-08-20T02:59:11ZengTaylor & Francis GroupEmerging Microbes and Infections2222-17512021-01-0110116116610.1080/22221751.2021.1873073Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the BD MAX open systemHsing-Yi Chung0Ming-Jr Jian1Chih-Kai Chang2Jung-Chung Lin3Kuo-Ming Yeh4Chien-Wen Chen5Sheng-Kang Chiu6Yi-Hui Wang7Shu-Jung Liao8Shih-Yi Li9Shan-Shan Hsieh10Shih-Hung Tsai11Cherng-Lih Perng12Ji-Rong Yang13Ming-Tsan Liu14Feng-Yee Chang15Hung-Sheng Shang16Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCDivision of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCDivision of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCDivision of Infectious Diseases and Tropical Medicine, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCDivision of Infectious Diseases and Tropical Medicine, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCDivision of Infectious Diseases and Tropical Medicine, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCDivision of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCDivision of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCDivision of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCDivision of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCDepartment of Emergency Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCDivision of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCCenters for Disease Control, Taipei, Taiwan, ROCCenters for Disease Control, Taipei, Taiwan, ROCDivision of Infectious Diseases and Tropical Medicine, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCDivision of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCSARS-CoV-2 has spread rapidly, causing deaths worldwide. In this study, we evaluated the performance of the BD MAX Open System module for identifying viral pathogens, including SARS-CoV-2, in nasopharyngeal specimens from individuals with symptoms of upper respiratory tract infection. We developed and validated a rapid total nucleic acid extraction method based on real-time reverse transcription-polymerase chain reaction (RT-PCR) for the reliable, high-throughput simultaneous detection of common cold viral pathogens using the BD MAX Platform. The system was evaluated using 205 nasopharyngeal swab clinical samples. For assessment of the limit of detection (LoD), we used SARS-CoV-2, influenza A/B, and respiratory syncytial virus (RSV) RNA standards. The BD MAX dual multiplex real-time RT-PCR panel demonstrated a sensitivity comparable to that of the World Health Organization-recommended SARS-CoV-2 assay with an LoD of 50 copies/PCR. The LoD of influenza A/B and RSV was 100–200 copies/PCR. The overall percent agreement between the BD MAX panel and laboratory-developed RT-PCR test on 55 SARS-CoV-2-positive clinical samples was 100%. Among the 55 positive cases of COVID-19 analysed, no coinfection was detected. The BD MAX rapid multiplex PCR provides a highly sensitive, robust, and accurate assay for the rapid detection of SARS-CoV-2, influenza A/B, and RSV.https://www.tandfonline.com/doi/10.1080/22221751.2021.1873073SARS-CoV-2COVID-19influenzarespiratory syncytial virussimultaneous detectionreal-time PCR
spellingShingle Hsing-Yi Chung
Ming-Jr Jian
Chih-Kai Chang
Jung-Chung Lin
Kuo-Ming Yeh
Chien-Wen Chen
Sheng-Kang Chiu
Yi-Hui Wang
Shu-Jung Liao
Shih-Yi Li
Shan-Shan Hsieh
Shih-Hung Tsai
Cherng-Lih Perng
Ji-Rong Yang
Ming-Tsan Liu
Feng-Yee Chang
Hung-Sheng Shang
Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the BD MAX open system
Emerging Microbes and Infections
SARS-CoV-2
COVID-19
influenza
respiratory syncytial virus
simultaneous detection
real-time PCR
title Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the BD MAX open system
title_full Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the BD MAX open system
title_fullStr Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the BD MAX open system
title_full_unstemmed Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the BD MAX open system
title_short Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the BD MAX open system
title_sort novel dual multiplex real time rt pcr assays for the rapid detection of sars cov 2 influenza a b and respiratory syncytial virus using the bd max open system
topic SARS-CoV-2
COVID-19
influenza
respiratory syncytial virus
simultaneous detection
real-time PCR
url https://www.tandfonline.com/doi/10.1080/22221751.2021.1873073
work_keys_str_mv AT hsingyichung noveldualmultiplexrealtimertpcrassaysfortherapiddetectionofsarscov2influenzaabandrespiratorysyncytialvirususingthebdmaxopensystem
AT mingjrjian noveldualmultiplexrealtimertpcrassaysfortherapiddetectionofsarscov2influenzaabandrespiratorysyncytialvirususingthebdmaxopensystem
AT chihkaichang noveldualmultiplexrealtimertpcrassaysfortherapiddetectionofsarscov2influenzaabandrespiratorysyncytialvirususingthebdmaxopensystem
AT jungchunglin noveldualmultiplexrealtimertpcrassaysfortherapiddetectionofsarscov2influenzaabandrespiratorysyncytialvirususingthebdmaxopensystem
AT kuomingyeh noveldualmultiplexrealtimertpcrassaysfortherapiddetectionofsarscov2influenzaabandrespiratorysyncytialvirususingthebdmaxopensystem
AT chienwenchen noveldualmultiplexrealtimertpcrassaysfortherapiddetectionofsarscov2influenzaabandrespiratorysyncytialvirususingthebdmaxopensystem
AT shengkangchiu noveldualmultiplexrealtimertpcrassaysfortherapiddetectionofsarscov2influenzaabandrespiratorysyncytialvirususingthebdmaxopensystem
AT yihuiwang noveldualmultiplexrealtimertpcrassaysfortherapiddetectionofsarscov2influenzaabandrespiratorysyncytialvirususingthebdmaxopensystem
AT shujungliao noveldualmultiplexrealtimertpcrassaysfortherapiddetectionofsarscov2influenzaabandrespiratorysyncytialvirususingthebdmaxopensystem
AT shihyili noveldualmultiplexrealtimertpcrassaysfortherapiddetectionofsarscov2influenzaabandrespiratorysyncytialvirususingthebdmaxopensystem
AT shanshanhsieh noveldualmultiplexrealtimertpcrassaysfortherapiddetectionofsarscov2influenzaabandrespiratorysyncytialvirususingthebdmaxopensystem
AT shihhungtsai noveldualmultiplexrealtimertpcrassaysfortherapiddetectionofsarscov2influenzaabandrespiratorysyncytialvirususingthebdmaxopensystem
AT chernglihperng noveldualmultiplexrealtimertpcrassaysfortherapiddetectionofsarscov2influenzaabandrespiratorysyncytialvirususingthebdmaxopensystem
AT jirongyang noveldualmultiplexrealtimertpcrassaysfortherapiddetectionofsarscov2influenzaabandrespiratorysyncytialvirususingthebdmaxopensystem
AT mingtsanliu noveldualmultiplexrealtimertpcrassaysfortherapiddetectionofsarscov2influenzaabandrespiratorysyncytialvirususingthebdmaxopensystem
AT fengyeechang noveldualmultiplexrealtimertpcrassaysfortherapiddetectionofsarscov2influenzaabandrespiratorysyncytialvirususingthebdmaxopensystem
AT hungshengshang noveldualmultiplexrealtimertpcrassaysfortherapiddetectionofsarscov2influenzaabandrespiratorysyncytialvirususingthebdmaxopensystem